The Discounted Cash Flow (DCF) valuation of Dali Pharmaceutical Co Ltd (603963.SS) is 0.31 CNY. With the latest stock price at 1.18 CNY, the upside of Dali Pharmaceutical Co Ltd based on DCF is -73.7%.
Based on the latest price of 1.18 CNY and our DCF valuation, Dali Pharmaceutical Co Ltd (603963.SS) is a sell. selling 603963.SS stocks now will result in a potential gain of 73.7%.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 9.7% | 8.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (0.66) - 0.53 | 0.31 |
| Upside | -155.8% - -55.3% | -73.7% |